| P50 | author | Maria S Pombo-de-Oliveira | Q47102466 |
| P2093 | author name string | Gilda Alves | |
| | Camilla F C G de Andrade | |
| | Denise A Pereira | |
| | Ricardo Bigni | |
| P2860 | cites work | Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum | Q28117412 |
| | Truncation of macrophage-derived chemokine by CD26/ dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction | Q28296438 |
| | Dipeptidyl peptidase IV (DPIV/CD26) degradation of glucagon. Characterization of glucagon degradation products and DPIV-resistant analogs | Q30652020 |
| | CD26, let it cut or cut it down. | Q33702158 |
| | Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides | Q33788748 |
| | CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO. | Q33947051 |
| | Dipeptidyl peptidase IV-like molecules: homologous proteins or homologous activities? | Q34469696 |
| | Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV. | Q35154326 |
| | Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer | Q35612482 |
| | Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage | Q36380925 |
| | Discovery of JANUVIA (Sitagliptin), a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes | Q36757643 |
| | Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage. | Q37400834 |
| | Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. | Q39369861 |
| | Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma | Q40379465 |
| | Functional role of CD26 on human B lymphocytes | Q41377278 |
| | Amino-terminal truncation of procalcitonin, a marker for systemic bacterial infections, by dipeptidyl peptidase IV (DP IV). | Q44168742 |
| | Association of CD26 with CD45RA outside lipid rafts attenuates cord blood T-cell activation | Q44606441 |
| | (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes | Q45212807 |
| | Activation antigen expression on human T cells. I. Analysis by two-colour flow cytometry of umbilical cord blood, adult blood and lymphoid tissue. | Q51113016 |
| P433 | issue | 3 | |
| P921 | main subject | leukemia | Q29496 |
| P304 | page(s) | 708-714 | |
| P577 | publication date | 2009-06-01 | |
| P1433 | published in | Journal of Enzyme Inhibition and Medicinal Chemistry | Q15708877 |
| P1476 | title | CD26/DPPIV cell membrane expression and DPPIV activity in plasma of patients with acute leukemia. | |
| P478 | volume | 24 | |